fbpx
X
Popular Searches
Hemato-Oncology Cancer Treatment Rehabilitation Children Cancer Treatment CAR T THERAPY

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
x New Patient Current or Returning Refer a patient
search
stethoscope
default doctor image

Ohad Benjamini

  • MD
Department:
  • Hematology and Bone Marrow Transplantation
Specialties:
  • Internal medicine
  • Hematology
Languages:
  • English
  • Hebrew
Request Consultation

About

The Head of Sheba’s Chronic Lymphocytic Leukemia Clinic (CLL), Dr. Benjamini completed his medical studies at Semmelweis University, and went on to a chronic lymphocytic leukemia fellowship at MD Anderson, one of the world’s leading cancer treatment centers. A renowned CLL expert, Dr. Benjamini leads CLL research efforts at Sheba to provide patients with the highest level of care.

Conditions and treatment

  • Chronic Lymphocytic leukemia
  • Hodgkin’s Lymphoma
  • Benign hematology
  • Non Hodgkin’s Lymphoma
  • Lymphoproliferative diseases

Positions

  • Senior Specialist and Principal investigator in clinical trials in CLL at Hematooncology Department

Education and Training

  • Semmelweis University, Budapest Hungary
  • Residency in internal medicine at Meir Medical Center
  • Fellowship in the department of hematology and bone marrow transplantation at Chaim Sheba Medical Center
  • Fellowship at the department of leukemia at MD Anderson cancer center, Huston Texas

Board Certifications

  • Internal medicine
  • Hematology

Publications

Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As2O3) and all-trans retinoic acid (ATRA). Jain P, Konoplev S, Benjamini O, Romagura J, Burger JA.

Low rate of spleen involvement in sporadic Burkitt lymphoma at staging on PET-CT. Davidson T, Priel E, Schiby G, Raskin S, Chikman B, Nissan E, Benjamini O, Nissan J, Goshen E, Ben-Haim S, Salomon O, Avigdor A.

The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression. Abraham M, Klein S, Bulvik B, Wald H, Weiss ID, Olam D, Weiss L, Beider K, Eizenberg O, Wald O, Galun E, Avigdor A, Benjamini O, Nagler A, Pereg Y, Tavor S, Peled A.

All publications

Sheba Knowledge Base

Request a consultation

Sheba Medical Center provides innovative, personalized medical care to patients from around the world. We are the largest, most comprehensive hospital in the Middle East and dedicated to providing advanced and compassionate medicine for everyone.

We welcome all cases, including the rarest and the most challenging. Our medical teams collaborate to provide the best possible health outcomes. From your initial inquiry through the long-term follow-up care, we are here for you.

Request a consultation and a Sheba Case Manager will contact you shortly:

New Patient Current & Returning Patients Refer a Patient